Navigation Links
Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
Date:10/7/2008

r products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2008 and the quarterly report on Form 10-Q for the quarter ended July 31, 2008. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Barbara Lindheim

(800) 987-8256 (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
4. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
5. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
6. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
7. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
8. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
9. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
10. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 In industries such ... sectors, the machines are more and more connected and ... amounts of data are being harvested by numerous sensors ... number of connected machines is estimated at several dozen ... raises the fundamental question as to how big data ...
(Date:9/23/2014)... DUBLIN , Sept. 23, 2014 ... the "Company"), a biotechnology company pioneering the manufacturing ... in emerging nations, today announced that the Depository ... for DTC,s Deposit and Withdrawal at Custodian ("DWAC") ... ("FAST") transfer agent as the distribution point.  The ...
(Date:9/23/2014)... 2014 This test can detect HIV infection if ... defined by activities that can transfer body fluids from one ... any shared needles. , An in-vitro diagnostic home-use ... HIV test works by looking for your body,s response to ... minutes, enabling patients to learn their status in a single ...
Breaking Medicine Technology:TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2
... - Ambrilia,Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing,novel ... and,cancer, held its Annual General and Special Meeting ... novel series of HIV,integrase inhibitors and recent developments ... Chairman of the Board, Mr. Frederic,Porte, and a ...
... 2007 /PRNewswire/ -- Results of the,Option (TOcilizumab ... first multinational Phase III study outside,of Japan, ... 4mg/kg,or 8mg/kg) plus methotrexate achieved a significant ... symptoms of moderate to,severe rheumatoid arthritis (RA) ...
Cached Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
(Date:9/23/2014)... New York (PRWEB) September 23, 2014 ... serious injury due to spontaneous migration of the birth ... U.S., Bernstein Liebhard LLP reports. According to court documents ... complaint that alleges migration of the IUD outside of ... her rectum. Her lawsuit, which is now pending in ...
(Date:9/23/2014)... 2014 Oaksterdam University has begun publishing ... its first post, the University addresses the need for ... industry. , The cannabis industry is becoming big business. ... an 18-month boost of more than $600 million in ... sales. And, the new legal recreational marijuana market in ...
(Date:9/23/2014)... studies found that FDG-PET technology is less accurate ... regions where infections like histoplasmosis or tuberculosis are ... cancer could lead to unnecessary tests and surgeries ... , Histoplasmosis and other fungal diseases are ... bird droppings and are found in soils. , ...
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows ... how it can be treated. , A medically retired ... 2006. His platoon sustained multiple attacks resulting in five ... with combat-related PTSD and honorably discharged from the Army. ... had distanced myself from my friends and family,” recalled ...
(Date:9/23/2014)... Doheny HealthDay Reporter TUESDAY, ... very low birth weights, breast milk is more likely than ... known as cytomegalovirus (CMV), a new study finds. The ... -- all of whom weighed 3.3 pounds or less and ... CMV infection, to see whether breast milk or transfusions carried ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 4Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3
... community-based oncology practices , , HOUSTON, June 10 ... nation,s foremost cancer treatment and research network and working with ... announces the launch of iKnowMed(TM) to ... health record (EHR) system designed by oncologists for ...
... ... $500 savings bond giveaway for expectant parents. M.A.Z.E. is dedicated to helping parents save ... ... -- Expectant parents can start investing for their child,s education with M.A.Z.E. Cord Blood Laboratories. ...
... 10 The Anthropedia Foundation, a non-profit organization with headquarters ... Switzerland, where it will host its first annual gala. The ... at Le Vieux Manoir, a five-star Relais & Chateaux Hotel ... artists, executives, doctors, scientists, and distinguished guests will enjoy a ...
... legally sell alcohol to teenagers after their sixteenth birthdays ... early age, but U.S. parents who follow this relaxed ... alcohol, should be careful -- it may increase the ... conducted by Caitlin Abar, graduate student, human development and ...
... 10 PIBH recognized 23 outstanding Pennsylvania workers and ... with disabilities, particularly in the workplace. , , ... at the Hilton Hotel in Harrisburg last night, celebrated ... day, however, PIBH honors the spirit and skills of ...
... , Havel,s partners with Canadian Hospital Specialties, to ... , , CINCINNATI, June 10 ... devices, has partnered with CHS, Canadian Hospital Specialties, ... EchoStim(R) and EchoBlock(R) Ultrasound Needles throughout Canada. , ...
Cached Medicine News:Health News:US Oncology Launches Oncology-Specific EHR to the Open Market 2Health News:US Oncology Launches Oncology-Specific EHR to the Open Market 3Health News:US Oncology Launches Oncology-Specific EHR to the Open Market 4Health News:M.A.Z.E. Cord Blood Laboratories Offers Expectant Parents The Chance To Win A $500 Savings Bond 2Health News:Anthropedia Foundation Charity Gala, Murten, Switzerland, in the Presence of HSH Prince Albert II of Monaco 2Health News:Zero tolerance alcohol policy good choice for parents 2Health News:PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities, 21 Organizations Supporting Those with Disabilities 2Health News:PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities, 21 Organizations Supporting Those with Disabilities 3Health News:PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities, 21 Organizations Supporting Those with Disabilities 4Health News:PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities, 21 Organizations Supporting Those with Disabilities 5Health News:PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities, 21 Organizations Supporting Those with Disabilities 6Health News:Havel's Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada 2
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: